Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma
Clinical trial NCT02336165 · COMPLETED
Trial details
- NCT number
- NCT02336165
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-26
- Primary completion
- 2018-11-01
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.